Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis

P Nallasamy, RK Nimmakayala, S Parte, AC Are… - Molecular cancer, 2022 - Springer
Cancer divergence has many facets other than being considered a genetic term. It is a
tremendous challenge to understand the metastasis and therapy response in cancer …

[HTML][HTML] Mechanisms of temozolomide resistance in glioblastoma-a comprehensive review

N Singh, A Miner, L Hennis, S Mittal - Cancer drug resistance, 2021 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and has an
exceedingly low median overall survival of only 15 months. Current standard-of-care for …

Challenges to curing primary brain tumours

K Aldape, KM Brindle, L Chesler, R Chopra… - Nature reviews Clinical …, 2019 - nature.com
Despite decades of research, brain tumours remain among the deadliest of all forms of
cancer. The ability of these tumours to resist almost all conventional and novel treatments …

Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment

LTH Phi, IN Sari, YG Yang, SH Lee, N Jun… - Stem cells …, 2018 - Wiley Online Library
Cancer stem cells (CSCs), also known as tumor‐initiating cells (TICs), are suggested to be
responsible for drug resistance and cancer relapse due in part to their ability to self‐renew …

Role of glioblastoma stem cells in cancer therapeutic resistance: A perspective on antineoplastic agents from natural sources and chemical derivatives

ALV Alves, INF Gomes, AC Carloni, MN Rosa… - Stem Cell Research & …, 2021 - Springer
Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most
aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior …

Pathological and molecular features of glioblastoma and its peritumoral tissue

A D'Alessio, G Proietti, G Sica, BM Scicchitano - Cancers, 2019 - mdpi.com
Glioblastoma (GBM) is one of the most aggressive and lethal human brain tumors. At
present, GBMs are divided in primary and secondary on the basis of the mutational status of …

Hedgehog signaling and truncated GLI1 in cancer

D Doheny, SG Manore, GL Wong, HW Lo - Cells, 2020 - mdpi.com
The hedgehog (HH) signaling pathway regulates normal cell growth and differentiation. As a
consequence of improper control, aberrant HH signaling results in tumorigenesis and …

Cancer stem cells: an evolving concept

LV Nguyen, R Vanner, P Dirks, CJ Eaves - Nature Reviews Cancer, 2012 - nature.com
The cancer stem cell (CSC) concept derives from the fact that cancers are dysregulated
tissue clones whose continued propagation is vested in a biologically distinct subset of cells …

Cancer stem cell hierarchy in glioblastoma multiforme

A Bradshaw, A Wickremsekera, ST Tan, L Peng… - Frontiers in …, 2016 - frontiersin.org
Glioblastoma multiforme (GBM), an aggressive tumor that typically exhibits treatment failure
with high mortality rates, is associated with the presence of cancer stem cells (CSCs) within …

Identification of human brain tumour initiating cells

SK Singh, C Hawkins, ID Clarke, JA Squire, J Bayani… - nature, 2004 - nature.com
The cancer stem cell (CSC) hypothesis suggests that neoplastic clones are maintained
exclusively by a rare fraction of cells with stem cell properties,. Although the existence of …